Vira Regen Competitors and Similar CompaniesClear all

CureVac's competitors and similar companies include Deciphera Pharmaceuticals, AnaptysBio and Biocon.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
AnaptysBio
AnaptysBio
AnaptysBio is a biotechnology company developing immunology therapeutic product candidates.
Biocon
Biocon
Biocon is a company that develops and manufactures biopharmaceutical products.
Founding Date
Founding Date
2000
Founding Date
2003
Founding Date
2005
Founding Date
1978
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
Waltham, US HQ
Lawrence, US
Locations
San Diego, US HQ
San Diego, US
Locations
Bengaluru, IN HQ
Bengaluru, IN
Nanakramguda, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
Delémont, CH
see more
Employees
Employees
82517% decrease
Employees
35037% increase
Employees
898% decrease
Employees
16,5612% increase
Valuation ($)
Valuation ($)
648.3 m
Valuation ($)
2.2 b
Valuation ($)
930.2 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
€535.2m (FY, 2024)
Revenue (est.)
$163.4m (FY, 2023)
Revenue (est.)
$234.6m (FY, 2025)
Revenue (est.)
₹167.8b (FY, 2026)
Cost of goods
Cost of goods
€9.7m (FY, 2024)
Cost of goods
$3.7m (FY, 2023)
Cost of goods
N/A
Cost of goods
₹56.9b (FY, 2026)
Gross profit
Gross profit
€534.4m (FY, 2024)
Gross profit
$159.6m (FY, 2023)
Gross profit
N/A
Gross profit
₹115.8b (FY, 2026)
Net income
Net income
€162.2m (FY, 2024)
Net income
($194.9m) (FY, 2023)
Net income
N/A
Net income
₹3.7b (FY, 2026)

Operating

Patent Applications
Patent Applications
500 (Mar, 2020)
Patent Applications
49 (Aug, 2017)
Patent Applications
N/A
Patent Applications
N/A

Funding

Total funding raised
Total funding raised
$ 1.1b
Total funding raised
$ 714m
Total funding raised
$ 83.9m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.

View company
AnaptysBio
HQ
San Diego, US
Employees
89↓ 8% decrease

AnaptysBio is a biotechnology company developing immunology therapeutic product candidates.

View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase

Biocon is a company that develops and manufactures biopharmaceutical products.

View company